Sensus Healthcare Inc Stock News

BOCA RATON, Fla. , March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will be presenting at the following investment conferences during March:

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passe

Sensus Healthcare (SRTS) board authorized a program to purchase up to $3M of shares.The current program represents ~2% of its current market cap; YTD, the stock gained 33.7%.

BOCA RATON, Fla, March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effec

BOCA RATON, Fla, March 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces that its Board of Directors has authorized a program to purchase up to $3,000,000 of shares of its Common Stock.

Sensus Healthcare, Inc. (SRTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passe

Biotech has been the worst performing sector of the stock market across the past 12 months.

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus Healthcare, Inc. (SRTS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Sensus Healthcare Inc (NASDAQ: SRTS ) sold its Sculptura assets to Empyrean Medical Systems for $15 million in cash . The sale included an inventory of Sculptura systems and parts, in addition to all related intellectual property. The Sculptura system provides targeted Directional Anisotropic Radiation Therapy (ART) and brachytherapy utilizing proprietary, state-of-the-art 3D Beam … Full story available on Benzinga.com

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion

In last trading session, Sensus Healthcare Inc. (NASDAQ:SRTS) saw 0.51 million shares changing hands with its beta currently measuring 0.33. Company’s recent per share price level of $10.67 trading at $0.75 or 7.56% at ring of the bell on the day assigns it a market valuation of $173.71M. That closing price of SRTS’s stock is … 12-Month Price Target For Sensus Healthcare Inc. (NASDAQ:SRTS) Now Sits At $17.50 Read More »

Sensus Healthcare Inc. (NASDAQ:SRTS) shares, rose in value on Friday, 02/18/22, with the stock price up by 2.04% to the previous days close as strong demand from buyers drove the stock to $10.49. Actively observing the price movement in the last trading, the stock closed the session at $10.28, falling within a range of $9.89 What Analysts Were Expecting After Sensus Healthcare Inc. (NASDAQ: SRTS) rose 2.04% Read More »

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our

If you are looking for stocks that are well positioned to maintain their recent uptrend, Sensus Healthcare, Inc. (SRTS) could be a great choice. It is one of the several stocks that passed through our